Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010.
about
Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia.The unique supportive care needs of a mother with acute myeloid leukemia during treatment.Cellular intrinsic mechanism affecting the outcome of AML treated with Ara-C in a syngeneic mouse model.Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.The Mediating Role of Mental Adjustment in the Relationship between Perceived Stress and Depressive Symptoms in Hematological Cancer Patients: A Cross-Sectional Study.Drug resistance: still a daunting challenge to the successful treatment of AML.Management of Cancer Related Distress in Patients with a Hematological Malignancy.Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groupsGan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model.Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemiaEfficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia.Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.Vesicular Stomatitis Virus G Glycoprotein and ATRA Enhanced Bystander Killing of Chemoresistant Leukemic Cells by Herpes Simplex Virus Thymidine Kinase/Ganciclovir.Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.Molecular-based classification of acute myeloid leukemia and its role in directing rational therapy: personalized medicine for profoundly promiscuous proliferations.Physiologic and psychological symptoms experienced by adults with acute leukemia: an integrative literature review.Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis.Triptolide induced cell death through apoptosis and autophagy in murine leukemia WEHI-3 cells in vitro and promoting immune responses in WEHI-3 generated leukemia mice in vivo.ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.GM-CSF-DFF40: a novel humanized immunotoxin induces apoptosis in acute myeloid leukemia cells.Immunotherapy of elderly acute myeloid leukemia: light at the end of a long tunnel?Exploring correlations between positive psychological resources and symptoms of psychological distress among hematological cancer patients: a cross-sectional study.Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults.Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway.Symptom Management and Psychosocial Needs of Adults With Acute Myeloid Leukemia During Induction Treatment: A Pilot Study.Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignancies.Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.Survival disparities by age and country of diagnosis for patients with acute leukemia.Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy.Has survival increased in cancer patients admitted to the ICU? Yes
P2860
Q33688129-12673275-B813-4C48-BA52-B5982B099F25Q33734101-FFA3270F-B7CC-4190-A29D-F7F55D046966Q35196705-3CEDAC8D-D55B-41C8-8EE0-7FB76913B378Q35331086-5A22EDE8-97BB-4F6C-B950-1723FCA3D0AFQ35740058-15854543-E95D-4E63-B8D0-32DEA11A2EACQ35847048-41090310-549F-46F7-B2FD-62AB00FDD6AEQ35946969-E3CFB780-E20F-4899-8E7D-812077B86286Q36243040-82027250-807A-47CD-AB6D-F779CB49EBB0Q36579091-EB09A977-0A37-4534-B939-9D9ADBC8805CQ36731075-F65DFB4B-1BA0-4374-991D-14DD276F97D4Q36739522-4C706381-43AC-4886-99F5-F84C4D1FED17Q36806921-E461A4FF-5BE8-41BB-8244-612F6DCD183AQ37310474-2F4AF847-295C-487C-8AD7-7690172C7C83Q37501821-1F800D81-CA92-4FFD-9160-ACC2262517D8Q37684212-36106916-4E85-4BC6-8CF0-2BC48C1364E6Q37702727-A21E3641-69D9-4987-903D-520829FBF723Q37810123-DD71F7CF-6F2A-49DB-83D9-3DC7B99F9440Q38062865-53E961CB-2B90-453E-992D-0E1650E085BFQ38207453-CA0650F9-DC4E-4108-A4F7-6F3D3E8D230AQ38681408-4A44900D-6F96-4541-B53D-E6040828E1E4Q38785183-C97BEF5C-07F4-4804-A121-3AFBF6588D2BQ39005733-889D0675-9CBC-4E88-83B4-6D8FBB1E57C1Q39175700-322C69B8-C91A-4779-B3AE-64B0D35D165FQ39205106-BEC6D571-0F6C-4116-B3F7-8551835A853FQ39285417-1E3D30DC-B0FB-4318-984A-2ABF8F2D7707Q39768527-14F879AF-88E4-47A4-A90B-52BC9B8720FDQ42111132-C8352DCC-62A9-402D-9919-8781C828550BQ45042500-3FE48F34-60B4-4855-9418-1A3CA638704DQ47567777-1E2FF740-DB34-4650-B46B-C74C9754A0F3Q48196149-FDEF2F35-AC83-464F-AE2D-EDE2F9C62040Q50960101-557BF534-FA51-476B-BCBC-2F548BED4E0FQ51139025-38FA71F3-0907-4DC5-B61B-FCDD1C34A453Q55090588-FC9C9AB7-76B2-452E-8AFB-436F4F09DB4DQ56968003-5D32C26F-5BE2-4D66-B12F-81E6E11FAB44
P2860
Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Expected long-term survival of ...... tic leukemia during 2006-2010.
@en
Expected long-term survival of ...... tic leukemia during 2006-2010.
@nl
type
label
Expected long-term survival of ...... tic leukemia during 2006-2010.
@en
Expected long-term survival of ...... tic leukemia during 2006-2010.
@nl
prefLabel
Expected long-term survival of ...... tic leukemia during 2006-2010.
@en
Expected long-term survival of ...... tic leukemia during 2006-2010.
@nl
P2860
P356
P1433
P1476
Expected long-term survival of ...... tic leukemia during 2006-2010.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDP309
P577
2009-07-24T00:00:00Z